Activation of Central Pain Pathways in Rheumatic Diseases: What We have Learned from Functional Neuroimaging Studies

被引:0
|
作者
Sofat, Nidhi [1 ]
Hamann, Philip [2 ]
Barrick, Thomas R. [3 ]
Howe, Franklyn A. [3 ]
机构
[1] St Georges Univ London, Div Basic Med Sci, London SW17 ORE, England
[2] Guys & St Thomas Hosp, Dept Med, London SE1 7EH, England
[3] St Georges Univ London, Div Cardiac & Vasc Sci, London SW17 ORE, England
关键词
Pain; rheumatic disease; fibromyalgia; fMRI (functional Magnetic Resonance Imaging); osteoarthritis; PET (positron emission tomography); MEG (magnetoencephalography); rheumatoid arthritis; SPECT (Single photon emission computed tomography);
D O I
10.2174/157339710791792694
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pain is a major symptom in rheumatic diseases. Understanding the nature of patients' pain symptoms in a rheumatology setting is integral to their assessment and optimising care. In recent years we have increasingly come to appreciate that not only is pain dependent on the underlying pathological process, but is also influenced by a number of additional factors that include genetics, the environment of the individual, previous pain experience and psychological status. Although local inflammation in the joint leads to the release of pro-inflammatory mediators including prostaglandins and cytokines that activate nociceptive signals in the joint, recent work has suggested that central activation of the brain is also important in mediating chronic pain in a number of rheumatic conditions including rheumatoid arthritis, fibromyalgia, osteoarthritis and back pain. A number of imaging modalities have been utilized in recent years to gain a deeper understanding of the pathways involved in the perception of pain in the rheumatic diseases. Functional Magnetic Resonance Imaging (fMRI), has been used to assess how the brain responds to and also mediates pain in the presence of arthritic disease. Positron emission tomography (PET) and Single photon emission computed tomography (SPECT) can produce blood flow images of the brain, or with the appropriate choice of radiopharmaceutical can also be used to image metabolic activity or specific neuroreceptors. Magnetoencephalography (MEG) can map cortical brain activity with high temporal resolution. These techniques have shown altered regional cerebral blood flow in areas of the brain in rheumatoid arthritis and fibromyalgia and have been used to determine pathways implicated in the perception of pain in specific conditions including complex regional pain syndrome and fibromyalgia. The information gained from functional imaging studies has improved our understanding of pain perception in rheumatic diseases and so may aid a more effective treatment for pain as will be discussed further in this review.
引用
收藏
页码:208 / 215
页数:8
相关论文
共 50 条
  • [21] Human visual object recognition: What have we learned from neuroimaging?
    Aguirre, GK
    Farah, MJ
    PSYCHOBIOLOGY, 1998, 26 (04) : 322 - 332
  • [22] Central tolerance: what have we learned from mice?
    Tom M. McCaughtry
    Kristin A. Hogquist
    Seminars in Immunopathology, 2008, 30 : 399 - 409
  • [23] Cluster headache pathophysiology: What we have learned from advanced neuroimaging
    Silvestro, Marcello
    Tessitore, Alessandro
    Orologio, Ilaria
    Battista, Giorgia
    Siciliano, Mattia
    Tedeschi, Gioacchino
    Russo, Antonio
    HEADACHE, 2022, 62 (04): : 436 - 452
  • [24] What Have We Learned From Brain Functional Connectivity Studies in Migraine Headache?
    Maleki, Nasim
    Gollub, Randy L.
    HEADACHE, 2016, 56 (03): : 453 - 461
  • [25] Pain and the placebo - what we have learned
    Hoffman, GA
    Harrington, A
    Fields, HL
    PERSPECTIVES IN BIOLOGY AND MEDICINE, 2005, 48 (02) : 248 - 265
  • [26] What have we learned on aging from omics studies?
    Cellerino, Alessandro
    Ori, Alessandro
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2017, 70 : 177 - 189
  • [27] What have we learned from proteomic studies of serum?
    Conrads, TP
    Veenstra, TD
    EXPERT REVIEW OF PROTEOMICS, 2005, 2 (03) : 279 - 281
  • [28] SYNFLORIX™: WHAT HAVE WE LEARNED FROM IMMUNOGENICITY STUDIES?
    Wysocki, J.
    PEDIATRIC RESEARCH, 2010, 68 : 1 - 2
  • [29] Editorial: What have we learned from studies of migrants?
    Margaret McCredie
    Cancer Causes & Control, 1998, 9 : 1 - 2
  • [30] Acute Pelvic Pain What We Have Learned From the ER
    Allison, Sandra O.
    Lev-Toaff, Anna S.
    ULTRASOUND QUARTERLY, 2010, 26 (04) : 211 - 218